PharVision Advisers’s Northrim BanCorp NRIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-18,884
Closed -$503K 471
2025
Q4
$503K Buy
+18,884
New +$448K 0.25% 41

Other funds holding NRIM

PharVision Advisers's NRIM Position: Q1 2026 in Review

PharVision Advisers sold out of Northrim BanCorp (NRIM) in Q1 2026, closing a stake of 18,884 shares — an estimated $503K sold.

PharVision Advisers first reported a position in NRIM in Q4 2025 and held it in 1 quarter. The position peaked at $503K in Q4 2025. 161 funds tracked by Wall St. Rank hold NRIM as of Q1 2026.

  • PharVision Advisers reported no remaining Northrim BanCorp position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 18,884 Northrim BanCorp shares in Q1 2026, an estimated $503K.
  • PharVision Advisers first reported a position in Northrim BanCorp in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Northrim BanCorp position peaked at $503K in Q4 2025.
  • 161 funds tracked by Wall St. Rank held Northrim BanCorp as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.